OrbiMed’s Silverstein discloses Parkinson’s diagnosis, plans to stay in role

Photo of Jonathan Silverstein courtesy of Silverstein Foundation
  • Silverstein to stay in role as global co-head of PE
  • Been with firm since 1998
  • Has launched foundation with his wife to research disease
Jonathan Silverstein, partner at healthcare investor OrbiMed Advisors, has been diagnosed with a rare form of Parkinson’s disease, but will continue full-time in his role as global co-head of private equity at the firm, he said in a letter to ...

This content is available for Buyouts subscribers only. Request a free trial to get access for a limited period

If you already have an active Buyouts subscription, please sign in to view this article.

Digital Edition


To read a digital copy of our latest magazine

click here

PE News Briefs